Parametric Portfolio Associates’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $4.23M | Buy |
53,273
+7,087
| +15% | +$639K | ﹤0.01% | 1966 |
|
|
2021
Q4 | $4.67M | Buy |
46,186
+3,707
| +9% | +$370K | ﹤0.01% | 1914 |
|
|
2021
Q3 | $3.92M | Sell |
42,479
-11,048
| -21% | -$1.06M | ﹤0.01% | 2000 |
|
|
2021
Q2 | $5.48M | Buy |
53,527
+3,590
| +7% | +$360K | ﹤0.01% | 1791 |
|
|
2021
Q1 | $4.87M | Buy |
49,937
+1,168
| +2% | +$106K | ﹤0.01% | 2196 |
|
|
2020
Q4 | $3.76M | Buy |
48,769
+4,185
| +9% | +$324K | ﹤0.01% | 2267 |
|
|
2020
Q3 | $3.28M | Buy |
44,584
+618
| +1% | +$49.6K | ﹤0.01% | 2186 |
|
|
2020
Q2 | $3.23M | Sell |
43,966
-2,060
| -4% | -$162K | ﹤0.01% | 2193 |
|
|
2020
Q1 | $2.66M | Sell |
46,026
-8,989
| -16% | -$625K | ﹤0.01% | 2198 |
|
|
2019
Q4 | $4.32M | Sell |
55,015
-8,058
| -13% | -$594K | ﹤0.01% | 2166 |
|
|
2019
Q3 | $4.31M | Buy |
63,073
+8,336
| +15% | +$560K | ﹤0.01% | 2120 |
|
|
2019
Q2 | $4.35M | Sell |
54,737
-8,069
| -13% | -$640K | ﹤0.01% | 2121 |
|
|
2019
Q1 | $5.27M | Sell |
62,806
-8,144
| -11% | -$850K | ﹤0.01% | 1956 |
|
|
2018
Q4 | $8.35M | Buy |
70,950
+8,481
| +14% | +$981K | 0.01% | 1474 |
|
|
2018
Q3 | $7.53M | Buy |
62,469
+1,011
| +2% | +$125K | 0.01% | 1670 |
|
|
2018
Q2 | $7.09M | Buy |
61,458
+28,849
| +88% | +$3.16M | 0.01% | 1658 |
|
|
2018
Q1 | $2.8M | Buy |
32,609
+6,664
| +26% | +$516K | ﹤0.01% | 2358 |
|
|
2017
Q4 | $1.92M | Buy |
25,945
+658
| +3% | +$44K | ﹤0.01% | 2633 |
|
|
2017
Q3 | $1.46M | Sell |
25,287
-1,275
| -5% | -$75.3K | ﹤0.01% | 2789 |
|
|
2017
Q2 | $1.7M | Buy |
26,562
+2,347
| +10% | +$145K | ﹤0.01% | 2652 |
|
|
2017
Q1 | $1.4M | Sell |
24,215
-41
| -0.2% | -$2.45K | ﹤0.01% | 2685 |
|
|
2016
Q4 | $1.48M | Sell |
24,256
-4,582
| -16% | -$299K | ﹤0.01% | 2586 |
|
|
2016
Q3 | $2M | Sell |
28,838
-1,728
| -6% | -$114K | ﹤0.01% | 2341 |
|
|
2016
Q2 | $1.7M | Sell |
30,566
-894
| -3% | -$53.9K | ﹤0.01% | 2439 |
|
|
2016
Q1 | $1.91M | Sell |
31,460
-10,762
| -25% | -$634K | ﹤0.01% | 2437 |
|
|
2015
Q4 | $2.7M | Sell |
42,222
-342
| -0.8% | -$22.2K | ﹤0.01% | 1979 |
|
|
2015
Q3 | $2.85M | Sell |
42,564
-2,108
| -5% | -$149K | 0.01% | 1569 |
|
|
2015
Q2 | $3.05M | Sell |
44,672
-8,058
| -15% | -$511K | 0.01% | 1840 |
|
|
2015
Q1 | $2.93M | Sell |
52,730
-16,448
| -24% | -$843K | 0.01% | 1862 |
|
|
2014
Q4 | $3.55M | Sell |
69,178
-7,932
| -10% | -$389K | 0.01% | 1593 |
|
|
2014
Q3 | $2.84M | Buy |
77,110
+8,312
| +12% | +$300K | 0.01% | 1714 |
|
|
2014
Q2 | $2.69M | Buy |
68,798
+1,412
| +2% | +$52.4K | 0.01% | 1785 |
|
|
2014
Q1 | $2.54M | Buy |
67,386
+23,456
| +53% | +$819K | 0.01% | 1795 |
|
|
2013
Q4 | $1.66M | Buy |
43,930
+10,774
| +32% | +$412K | ﹤0.01% | 2218 |
|
|
2013
Q3 | $1.44M | Buy |
33,156
+5,444
| +20% | +$218K | ﹤0.01% | 2235 |
|
|
2013
Q2 | $1M | Buy |
+27,712
| New | +$842K | ﹤0.01% | 2429 |
|
Other funds holding USNA
Parametric Portfolio Associates's USNA Position: Q1 2022 in Review
Parametric Portfolio Associates increased its Usana Health Sciences (USNA) stake by 15% in Q1 2022, buying an estimated $639K and bringing the position to 53,273 shares worth $4.23M. The position accounts for ﹤0.01% of the portfolio, ranked #1966.
Parametric Portfolio Associates first reported a position in USNA in Q2 2013 and has held it in 36 quarters since. The position peaked at $8.35M in Q4 2018. 179 funds tracked by Wall St. Rank hold USNA as of Q1 2022.
- Parametric Portfolio Associates held 53,273 shares of Usana Health Sciences worth $4.23M as of Q1 2022.
- Parametric Portfolio Associates bought 7,087 Usana Health Sciences shares in Q1 2022, an estimated $639K.
- Usana Health Sciences made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #1966 holding.
- Parametric Portfolio Associates first reported a position in Usana Health Sciences in Q2 2013 and has held it in 36 quarters since.
- Parametric Portfolio Associates's Usana Health Sciences position peaked at $8.35M in Q4 2018.
- 179 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.